Corporate news

Dividend raised to EUR 0.70 per share Management Board and Supervisory Board given formal approval by large majority Dr. Axel Herberg new member…

Düsseldorf/Peachtree City (Georgia/USA), March 10, 2014 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry,…

Third-quarter revenues up 1.8% (+4.5% excluding exchange rate effects), to EUR 316.9m Adjusted EBITDA reaches EUR 61.6m (prior-year quarter: EUR…

Düsseldorf, April 18, 2013 – A dividend of EUR 0.65 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Düsseldorf.…

Production of components for a further Sanofi insulin pen Düsseldorf, April 16, 2013. Gerresheimer has commenced production of components for another…

First-quarter revenues up 10.4% to EUR 296.7m Adjusted EBITDA margin reaches 15.5% Net income grows by 41.7% to EUR 10.2m Adjusted earnings per…

Updated version March 08, 2013 Updated: 6th paragraph, last sentence New: “unlike in previous years” and “not payable tax free” Revenues rise by…

Düsseldorf/New Delhi, December 18, 2012 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, today announced…

Düsseldorf, October 23, 2012 – Rainer Beaujean will join the Gerresheimer AG Management Board on December 1, 2012 and assume the function of CFO on…